Jennifer Viera | Investor Relations |
Jay Luly | President and Chief Executive Officer |
Paul Mellett | Chief Financial Officer |
Tara Kieffer | Senior Vice President of New Product Strategy and Development |
Brian Abrahams | RBC Capital Markets |
Jay Olson | Oppenheimer |
Ed Arce | H.C. Wainwright |
Eric Joseph | JP Morgan |
Roy Buchanan | JMP Securities |
Luke Herrmann | Baird |
Good afternoon, and welcome to Enanta Pharmaceuticals’ Fiscal Third Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode. There will be a question-and-answer session at the end of prepared remarks. Please be advised that this call is being recorded.
I would now like to turn the call over to Jennifer Viera, Investor Relations.